Clinical Biochemistry Practice Questions

Q: Plasma alkaline phosphatase levels are highest in which of the following conditions?

Biliary cirrhosis. **Explanation:** **Alkaline Phosphatase (ALP)** is a marker enzyme for the canalicular membrane of hepatocytes. Its elevation is the hallmark of **cholestasis** (impairment of bile flow). **Why Biliary Cirrhosis is correct:** In **Biliary Cirrhosis** (specifically Primary Biliary Cholangitis), there is chronic inflammation and destruction of the intrahepatic bile ducts. This leads to significant cholestasis. The increased pressure within the bile canaliculi induces the synthesis of ALP by hepatocytes and facilitates its leakage into the bloodstream. Consequently, ALP levels in biliary cirrhosis are typically elevated to **more than 3 to 10 times** the upper limit of normal (ULN). **Why other options are incorrect:** * **Alcoholic, Postnecrotic, and Cardiac Cirrhosis:** These conditions primarily involve **hepatocellular damage** or venous congestion rather than primary biliary obstruction. While ALP may be slightly elevated in these conditions, the rise is usually mild (less than 2-3 times ULN). In these cases, markers of hepatocellular injury like ALT and AST are more prominent. **High-Yield Clinical Pearls for NEET-PG:** * **ALP Isoenzymes:** If ALP is elevated, check **GGT (Gamma-glutamyl transferase)** to confirm the origin. If both are high, the source is hepatobiliary; if only ALP is high, consider bone pathology (e.g., Paget’s disease). * **Highest ALP levels:** Seen in **Extrahepatic biliary obstruction** (e.g., Gallstones, Carcinoma head of pancreas) and **Paget’s disease of bone**. * **Heat Stability:** Placental ALP is the most heat-stable (Regan isoenzyme), while Bone ALP is the most heat-labile. (*Mnemonic: Bone is Burned easily*).

Q: Troponin-T is a marker of?

Myocardial infarction. **Explanation:** **Troponin-T (cTnT)** is a structural protein that regulates the interaction between actin and myosin in cardiac muscle. It is a highly specific and sensitive biochemical marker for **Myocardial Infarction (MI)**. When cardiac myocytes are damaged due to ischemia, troponins are released into the bloodstream. cTnT begins to rise within 3–4 hours of injury, peaks at 12–24 hours, and remains elevated for up to 10–14 days, making it useful for both acute diagnosis and late detection of MI. **Analysis of Incorrect Options:** * **A. Renal diseases:** While troponin levels can be chronically elevated in end-stage renal disease (ESRD) due to decreased clearance or silent cardiac strain, it is not a diagnostic marker for renal pathology. Creatinine and Urea are the primary markers for renal disease. * **B. Muscular dystrophy:** Skeletal muscle damage is typically monitored using **Creatine Kinase (CK-MM)** and Aldolase. While Troponin-T has a skeletal isoform, the clinical assay is specific to the cardiac isoform (cTnT), which does not rise in primary muscular dystrophies. * **C. Cirrhosis of liver:** Liver damage is assessed using Liver Function Tests (LFTs) such as ALT, AST, Bilirubin, and Albumin. Troponin has no physiological role in hepatic tissue. **High-Yield Clinical Pearls for NEET-PG:** * **Troponin I (cTnI)** is considered even more cardio-specific than Troponin T because cTnT can occasionally be elevated in certain skeletal muscle myopathies. * **Earliest Marker:** Myoglobin is the earliest marker to rise (1–3 hours) but lacks specificity. * **Marker for Re-infarction:** **CK-MB** is the investigation of choice for detecting a second MI occurring shortly after the first, as it returns to baseline within 48–72 hours, unlike Troponins. * **Gold Standard:** Cardiac Troponins are currently the "Gold Standard" for the diagnosis of MI.

Q: Obstructive liver disease is associated with a rise in which of the following?

Alkaline phosphatase. **Explanation:** The correct answer is **Alkaline Phosphatase (ALP)**. In **obstructive liver disease** (cholestasis), there is an obstruction to the flow of bile. This leads to an accumulation of bile salts, which act as detergents and solubilize the membranes of the bile canaliculi. This process triggers the **de novo synthesis** of ALP by the biliary canalicular cells. Consequently, ALP levels rise significantly (often >3 times the upper limit of normal), making it the hallmark biochemical marker for cholestasis. **Analysis of Incorrect Options:** * **A & B (AST and ALT):** These are markers of **hepatocellular injury**. While they may rise slightly in obstructive jaundice, their primary elevation occurs when hepatocytes are damaged (e.g., viral hepatitis or toxins). * **D (Serum Albumin):** Albumin is a marker of the liver's **synthetic function**. In acute obstructive disease, albumin levels usually remain normal. A decrease in albumin typically indicates chronic liver disease (e.g., cirrhosis). **High-Yield Clinical Pearls for NEET-PG:** * **GGT (Gamma-Glutamyl Transferase):** This is the most sensitive marker for biliary obstruction and is used to confirm that an elevated ALP is of hepatic origin (as ALP also rises in bone diseases). * **ALP Isoenzymes:** Remember the mnemonic **"BALI"** (Bone, Abdomen/Intestine, Liver, Intestine/Placenta) for the sources of ALP. * **Regan Isoenzyme:** A placental-like ALP isoenzyme that acts as a tumor marker (e.g., in seminoma or lung cancer). * **Fractionated Bilirubin:** Obstructive jaundice is characterized by a rise in **Conjugated Bilirubin**, leading to clay-colored stools and dark urine (bilirubinuria).

Q: What is the serum Blood Urea Nitrogen (BUN) in a patient with a urea concentration of 52 mg/dL?

24.3 mg/dL. ### Explanation The relationship between **Urea** and **Blood Urea Nitrogen (BUN)** is based on their respective molecular weights. Urea ($NH_2CONH_2$) has a molecular weight of **60 Da**, while the two nitrogen atoms within the urea molecule have a combined atomic weight of **28 Da** ($14 \times 2$). To convert Urea to BUN, we use the ratio of their weights: $$\text{BUN} = \text{Urea} \times \left(\frac{28}{60}\right) \approx \text{Urea} \times 0.467$$ $$\text{Urea} = \text{BUN} \times \left(\frac{60}{28}\right) \approx \text{BUN} \times 2.14$$ **Calculation for this question:** $52 \text{ mg/dL (Urea)} \times 0.467 = \mathbf{24.28 \text{ mg/dL}}$ (Rounded to **24.3 mg/dL**). --- ### Analysis of Options: * **A (Correct):** Derived using the standard conversion factor ($52 / 2.14$). * **B & C (Incorrect):** These values do not correspond to any standard physiological ratio between urea and nitrogen. * **D (Incorrect):** This value is higher than the total urea concentration. BUN must always be lower than the total urea concentration because it only measures the nitrogen component of the molecule. --- ### High-Yield Clinical Pearls for NEET-PG: 1. **BUN:Creatinine Ratio:** Normal ratio is **10:1 to 20:1**. 2. **Prerenal Azotemia:** Characterized by a ratio **>20:1** (due to increased passive reabsorption of urea in the proximal tubule). 3. **Intrinsic Renal Disease:** Characterized by a ratio **<15:1** (due to tubular damage preventing reabsorption). 4. **Low BUN:** Seen in liver failure (decreased urea cycle activity), SIADH, and malnutrition. 5. **Urea Cycle:** Occurs in the liver; the first two steps occur in the **mitochondria**, while the remaining steps occur in the **cytosol**.

Q: Which test is used for the diagnosis of Dubin-Johnson syndrome?

Bromosulphalein test. **Explanation:** **Dubin-Johnson Syndrome (DJS)** is an autosomal recessive disorder characterized by a deficiency in the **MRP2 protein** (Multidrug Resistance-associated Protein 2), which is responsible for the ATP-dependent transport of conjugated bilirubin and other organic anions from hepatocytes into the bile canaliculi. **Why Bromosulphalein (BSP) test is correct:** The BSP test is a classic diagnostic tool for DJS. In healthy individuals, BSP dye is cleared from the blood by the liver and excreted into the bile. In DJS patients, there is a unique **"biphasic" response**: initial uptake is normal, but because the transport of the conjugated dye into the bile is defective, it refluxes back into the blood. This results in a characteristic **rise in serum BSP levels at 90–120 minutes** after the initial 45-minute clearance. **Analysis of Incorrect Options:** * **Gamma-Glutamyl Transferase (GGT):** Used to detect hepatobiliary disease and alcohol abuse; it is typically normal in DJS. * **Serum Amylase Test:** A marker used for diagnosing acute pancreatitis, unrelated to bilirubin metabolism. * **Hippuric Acid Test:** Historically used to assess the liver's detoxification capacity (conjugation of benzoic acid with glycine), not specific for DJS. **NEET-PG High-Yield Pearls for Dubin-Johnson Syndrome:** * **Clinical Feature:** Characterized by conjugated hyperbilirubinemia and a **"Black Liver"** due to the accumulation of melanin-like pigment in lysosomes. * **Urinary Coproporphyrins:** Total levels are normal, but **Coproporphyrin I** accounts for >80% (in healthy individuals, Coproporphyrin III predominates). * **Rotor Syndrome vs. DJS:** Rotor syndrome does *not* show the biphasic BSP curve and does *not* feature a black liver. * **Oral Cholecystography:** The gallbladder is usually not visualized in DJS due to the inability to excrete the radiopaque dye.

Q: Which of the following is a marker for bone formation?

Osteocalcin. **Explanation:** Bone remodeling is a continuous process involving bone formation by **osteoblasts** and bone resorption by **osteoclasts**. Markers of bone turnover are categorized based on which process they reflect. **Why Osteocalcin is correct:** **Osteocalcin** (Bone Gla Protein) is a non-collagenous protein synthesized specifically by mature **osteoblasts**. Its synthesis is Vitamin K and Vitamin D dependent. While most osteocalcin is incorporated into the bone matrix, a small fraction enters the circulation, making it a highly specific **marker of bone formation** and osteoblastic activity. **Analysis of Incorrect Options:** * **A. Tartrate-resistant acid phosphatase (TRAP):** This is an enzyme secreted by **osteoclasts**. It is a classic marker of **bone resorption**, not formation. * **B. Urinary calcium:** While elevated in states of high bone turnover (like hyperparathyroidism), it is a non-specific marker influenced by diet, renal function, and intestinal absorption. It generally reflects **bone resorption**. * **D. Serum nucleotidase (5'-Nucleotidase):** This is a marker for **hepatobiliary disease** (specifically cholestasis). It is used to differentiate whether an elevated Alkaline Phosphatase (ALP) is of hepatic or skeletal origin. **High-Yield Clinical Pearls for NEET-PG:** * **Other Bone Formation Markers:** Total and Bone-specific Alkaline Phosphatase (bALP), and Procollagen type 1 N-terminal propeptide (**P1NP**) — *P1NP is currently considered the most sensitive marker for bone formation.* * **Other Bone Resorption Markers:** Urinary **Hydroxyproline**, Pyridinoline, and C-telopeptide (**CTX**). * **Clinical Use:** These markers are used to monitor response to osteoporosis therapy (e.g., bisphosphonates) rather than for primary diagnosis.

Q: Which of the following groups represents negative acute phase proteins?

Transferrin, albumin, transthyretin. **Explanation:** Acute Phase Proteins (APPs) are plasma proteins whose concentrations change by at least 25% in response to inflammation, infection, or tissue injury, primarily mediated by cytokines like IL-6 and TNF-α. **1. Why Option A is Correct:** **Negative Acute Phase Proteins** are those whose serum concentrations **decrease** during acute inflammation. The liver prioritizes the synthesis of "positive" reactants, leading to a downregulation of others. * **Albumin:** The most abundant plasma protein; levels drop to conserve amino acids for positive APPs. * **Transferrin:** Decreases to sequester iron away from pathogens (which require iron for replication). * **Transthyretin (Pre-albumin):** A sensitive marker of nutritional status and inflammation that rapidly declines during the acute phase. **2. Analysis of Incorrect Options:** * **Option B:** While Albumin is negative, **CRP (C-Reactive Protein)** and **Haptoglobin** are positive APPs (their levels increase). * **Option C:** **Haptoglobin, Ceruloplasmin, and Fibrinogen** are all positive APPs. Ceruloplasmin acts as a ferroxidase, and Fibrinogen is essential for clot formation. * **Option D:** **CRP, α-1 antitrypsin, and Fibrinogen** are all positive APPs. α-1 antitrypsin acts as a protease inhibitor to protect tissues from inflammatory enzymes. **3. NEET-PG High-Yield Pearls:** * **Most sensitive/fastest positive APP:** C-Reactive Protein (CRP). * **ESR vs. CRP:** ESR is an indirect measure of inflammation (driven largely by Fibrinogen), whereas CRP is a direct biochemical marker. * **Retinol-Binding Protein (RBP):** Another high-yield negative APP often tested alongside albumin. * **Procalcitonin:** A specific marker used to differentiate bacterial infections from viral or non-infectious inflammation.

Q: Vanillylmandelic acid (VMA) is a metabolite of:

Adrenaline. **Explanation:** **Why Adrenaline is correct:** Vanillylmandelic acid (VMA) is the end-stage metabolic byproduct of **catecholamines**, specifically **Adrenaline (Epinephrine)** and **Noradrenaline (Norepinephrine)**. The metabolic pathway involves two key enzymes: **COMT** (Catechol-O-methyltransferase) and **MAO** (Monoamine oxidase). Adrenaline is first converted to Metanephrine and subsequently oxidized to VMA, which is then excreted in the urine. **Why the other options are incorrect:** * **Thyroxine (T4):** This is a thyroid hormone derived from Tyrosine. Its metabolism involves deiodination (conversion to T3 or rT3) and conjugation in the liver, not VMA production. * **Serotonin:** The major end-metabolite of serotonin (5-hydroxytryptamine) is **5-HIAA** (5-Hydroxyindoleacetic acid). Elevated 5-HIAA is a marker for Carcinoid syndrome. * **Growth Hormone:** This is a peptide hormone. Like all proteins, it is degraded into its constituent amino acids by proteolysis. **Clinical Pearls for NEET-PG:** 1. **Pheochromocytoma:** Urinary VMA levels are measured in a **24-hour urine collection** to diagnose Pheochromocytoma (a catecholamine-secreting tumor of the adrenal medulla). 2. **Neuroblastoma:** VMA is also a critical tumor marker for Neuroblastoma in children. 3. **Dietary Restrictions:** Before a VMA test, patients must avoid "VMA-rich" foods like vanilla, chocolate, coffee, and bananas, as they can cause false-positive results. 4. **Metanephrines:** Note that urinary metanephrines are generally considered more sensitive than VMA for screening purposes.

Q: Which liver enzyme elevation suggests bile duct obstruction?

Alkaline phosphatase (ALP). **Explanation:** The correct answer is **Alkaline phosphatase (ALP)**. **1. Why ALP is the correct answer:** Alkaline phosphatase is an enzyme found primarily in the cells lining the biliary canaliculi of the liver. In the setting of **cholestasis** (bile duct obstruction), the increased pressure from bile stasis triggers the de novo synthesis of ALP and its subsequent release into the bloodstream. Therefore, a disproportionate rise in ALP compared to aminotransferases is the hallmark of an **obstructive (post-hepatic) jaundice** pattern. **2. Why the other options are incorrect:** * **ALT (Alanine aminotransferase) & AST (Aspartate aminotransferase):** These are markers of **hepatocellular injury**. They are located within the hepatocytes. While they may rise slightly in obstruction, their primary elevation occurs in conditions like viral hepatitis or toxin-induced liver damage. ALT is more specific to the liver than AST. * **Aminotransferase:** This is a general term for the group containing ALT and AST; it is not specific for biliary obstruction. **3. NEET-PG High-Yield Clinical Pearls:** * **Confirmatory Test:** Since ALP is also found in bone, placenta, and intestine, **GGT (Gamma-glutamyl transferase)** is measured to confirm the hepatic origin of an elevated ALP. GGT is *not* elevated in bone disease. * **The "3-Fold Rule":** In obstructive jaundice, ALP typically rises to >3 times the upper limit of normal. * **Mnemonic:** **A**LP = **A**way (Obstruction/Bile flow blocked); **A**LT = **A**live (Hepatocyte damage). * **Other Biliary Markers:** 5'-Nucleotidase is another specific marker for biliary obstruction, often used alongside ALP.

Question 1

Plasma alkaline phosphatase levels are highest in which of the following conditions?

Accepted Answer

Biliary cirrhosis

Answer

Alcoholic cirrhosis

Answer

Postnecrotic cirrhosis

Answer

Cardiac cirrhosis

Question 2

Troponin-T is a marker of?

Accepted Answer

Myocardial infarction

Answer

Renal diseases

Answer

Muscular dystrophy

Answer

Cirrhosis of liver

Question 3

Obstructive liver disease is associated with a rise in which of the following?

Accepted Answer

Alkaline phosphatase

Answer

Aspartate aminotransferase

Answer

Alanine amino transferase

Answer

Serum albumin

Question 4

What is the serum Blood Urea Nitrogen (BUN) in a patient with a urea concentration of 52 mg/dL?

Accepted Answer

24.3 mg/dL

Answer

34.5 mg/dL

Answer

41.9 mg/dL

Answer

69.7 mg/dL

Question 5

Which test is used for the diagnosis of Dubin-Johnson syndrome?

Accepted Answer

Bromosulphalein test

Answer

Gamma Glutamyl Transferase

Answer

Serum Amylase Test

Answer

Hippuric acid test

Question 6

Which of the following is a marker for bone formation?

Accepted Answer

Osteocalcin

Answer

Tartrate resistant acid phosphatase

Answer

Urinary calcium

Answer

Serum nucleotidase

Question 7

Which of the following groups represents negative acute phase proteins?

Accepted Answer

Transferrin, albumin, transthyretin

Answer

Haptoglobulin, CRP, albumin

Answer

Haptoglobulin, ceruloplasmin, fibrinogen

Answer

CRP, a-1 antitrypsin, fibrinogen

Question 8

Which of the following are abnormal synthesis functions of the liver?

Accepted Answer

All of the above

Answer

Increased protein synthesis (IPT)

Answer

Hyperbilirubinemia

Answer

Decreased acute phase reactant synthesis

Question 9

Vanillylmandelic acid (VMA) is a metabolite of:

Accepted Answer

Adrenaline

Answer

Thyroxine

Answer

Serotonin

Answer

Growth hormone

Question 10

Which liver enzyme elevation suggests bile duct obstruction?

Accepted Answer

Alkaline phosphatase (ALP)

Answer

Aspartate aminotransferase (AST)

Answer

Alanine aminotransferase (ALT)

Answer

Aminotransferase

Clinical Biochemistry — MCQs

Clinical Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?